Skip to content
WeighLab
Menu
Ranked #467 · Grade C

Roboclinic review

RoboClinic is not a dedicated GLP-1 weight-loss brand.

Visit Roboclinic Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Pricing verified August 2026

The Index scorecard

Roboclinic scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month45/100
Price Transparency20/100
Nationwide Access24/100
Formulation Options64/100
Clinical Oversight84/100
Contract Flexibility55/100

Where the value is

  • AI-assisted intake could speed up the initial assessment step
  • Ultimately backed by OpenLoop Health, a real national telehealth clinical network
  • Positions itself as covering broader health assessments, not just weight loss

The tradeoffs

  • The roboclinic.com domain is dead/repurposed, redirecting to an unrelated business directory
  • No dedicated GLP-1/weight-loss pricing, plans, or medication menu found
  • Does not itself prescribe -- explicitly defers all clinical decisions to OpenLoop-affiliated providers
  • No named medical director, pharmacy partner, state list, or LegitScript status found

The bottom line

Best for: Cost-first shoppers who want likely a miscategorization -- not a genuine dedicated GLP-1 weight-loss storefront. RoboClinic is not a dedicated GLP-1 weight-loss brand.

Ranked #467 of 539 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 538 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Roboclinic.

The 19 programs nearest this one

Pricing, states and verification reflect Roboclinic's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Roboclinic's site. Not medical advice; see our disclosure.

← Back to the value leaderboard